The Lead Episode 158: A Discussion of Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

Availability

On-Demand

Cost

$0.00

Credit Offered

No Credit Offered

In this episode of The Lead, host Robert Schaller, DO, FHRS, is joined by Tina Baykaner, MD, MPH, and Maulin Shah, MD, to discuss the journal article, Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Together, they review the study's long-term follow-up findings and explore device-related complications associated with transvenous and subcutaneous defibrillator therapy.

Review the long-term follow-up results of the PRAETORIAN-XL Trial comparing transvenous and subcutaneous defibrillator therapy.
Discuss device-related complications associated with transvenous and subcutaneous implantable defibrillator systems.
Examine the clinical considerations of defibrillator therapy selection based on long-term device-related outcomes.

Podcast Contributors

Host: Robert Schaller, DO, FHRS

Guests:

Tina Baykaner, MD, MPH

Maulin Shah, MD

All relevant financial relationships have been mitigated.

Host and Contributor Disclosure(s):

R. Schaller

Honoraria/Speaking/Consulting Fee: Philips, Abbott Medical
Officer/Trustee/Director/Committee Chair/Other Fiduciary Role: Imricor
Other Financial Relationship: Other

T. Baykaner

Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic, Pacemate, Johnson & Johnson, Abbott Medical, Boston Scientific
Research: NIH, Boston Scientific

M Shah

No relevant disclosures

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
E. Downward: No relevant financial relationships with ineligible companies to disclose.